Literature DB >> 16696327

Effects of Icariin on expression of OPN mRNA and type I collagen in rat osteoblasts in vitro.

Qiangbing Xiao1, Anmin Chen, Fengjin Guo.   

Abstract

To study the effects of Icariin on expression of osteopontin (OPN) mRNA and type I collagen in rat osteoblasts in vitro and to explore its possible mechanisms in preventing osteoporosis. OB was isolated from calvaria of new-born new-born fetal Sprague-Dawley (SD) rats by means of modified sequential collagenase digestion and incubated in MEM medium and the cell morphology was observed under inverted phase contrast microscope, OB was identified by alkaline phosphatase (ALP) staining. Different concentration (0.1 microg/mL, 1.0 microg/ml, 10 microg/mL) of Icariin was added to the OB and incubated. The effect of Icariin on the proliferation and osteogenesis of OB was monitored by MTT analysis. The expression of type I collagen was estimated with immunohistochemistry techniques. The expression levels of mRNA of OPN in the cells in every group were examined by reverse-transcriptase ploymerase chain reaction (RT-PCR). The expression of OPN mRNA and type I collagen was strengthened gradually with the increase of Icariin concentration and peaked with 10 microg/mL Icariin on the 5th day. Icariin could significantly promote the expression of OPN mRNA and type I collagen in rat osteoblasts in vitro. The levels of expression of OPN mRNA and type I collagen were changed with different concentration of Icariin. Icariin could effectively prevent and treat osteoporosis and promote the bone formation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16696327     DOI: 10.1007/bf02896172

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  6 in total

1.  Recognition of osteopontin and related peptides by an alpha v beta 3 integrin stimulates immediate cell signals in osteoclasts.

Authors:  A Miyauchi; J Alvarez; E M Greenfield; A Teti; M Grano; S Colucci; A Zambonin-Zallone; F P Ross; S L Teitelbaum; D Cheresh
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

Review 2.  Osteopontin: a versatile regulator of inflammation and biomineralization.

Authors:  C M Giachelli; S Steitz
Journal:  Matrix Biol       Date:  2000-12       Impact factor: 11.583

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence.

Authors:  A Oldberg; A Franzén; D Heinegård
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

5.  Osteopontin--a possible anchor of osteoclasts to bone.

Authors:  F P Reinholt; K Hultenby; A Oldberg; D Heinegård
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

Review 6.  The nature and significance of osteopontin.

Authors:  W T Butler
Journal:  Connect Tissue Res       Date:  1989       Impact factor: 3.417

  6 in total
  3 in total

1.  Five-year follow-up study of a kidney-tonifying herbal Fufang for prevention of postmenopausal osteoporosis and fragility fractures.

Authors:  Wei-Min Deng; Peng Zhang; Hai Huang; You-Gao Shen; Qin-Hua Yang; Wei-Li Cui; Yang-Shu He; Song Wei; Zhu Ye; Fang Liu; Ling Qin
Journal:  J Bone Miner Metab       Date:  2012-06-22       Impact factor: 2.626

2.  Icariin induces osteogenic differentiation of bone mesenchymal stem cells in a MAPK-dependent manner.

Authors:  Yuqiong Wu; Lunguo Xia; Yuning Zhou; Yuanjin Xu; Xinquan Jiang
Journal:  Cell Prolif       Date:  2015-04-13       Impact factor: 6.831

3.  The dose-effect of icariin on the proliferation and osteogenic differentiation of human bone mesenchymal stem cells.

Authors:  Jun-Jun Fan; Liang-Guo Cao; Tao Wu; De-Xin Wang; Dan Jin; Shan Jiang; Zhi-Yong Zhang; Long Bi; Guo-Xian Pei
Journal:  Molecules       Date:  2011-12-06       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.